SpringWorks Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

SpringWorks Therapeutics

02/11/2023 11:47

* SpringWorks Therapeutics Inc  SWTX.OQ  reported a
quarterly
adjusted loss of $1.27​​ per share for the quarter ended in
September, higher than the same quarter last year, when the
company reported EPS of $-1.37.  The mean expectation of
six analysts for the quarter was for a loss of $1.33 per share.
Wall Street expected results to range from $-1.41 to $-1.15 per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * SpringWorks Therapeutics Inc's reported EPS for the
quarter was
a loss of $1.27​.
    * The company reported a quarterly loss of $79.44 million.
    * SpringWorks Therapeutics Inc shares had risen by 3.4% this
quarter and lost 8.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 6.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for SpringWorks
Therapeutics Inc is $47.00 

This summary was machine generated from LSEG data November 2 at
11:47 a.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -1.33          -1.27          Beat
 Jun. 30 2023      -1.26          -1.25          Beat
 Mar. 31 2023      -1.25          -1.18          Beat
 Dec. 31 2022      -1.22          -1.17          Beat